We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Disseminated actinomycetoma due to <italic>Nocardia wallacei</italic>.
- Authors
Welsh, Oliverio; Salinas‐Carmona, Mario C.; Brown‐Elliott, Barbara A.; Smith, Terry; Cardenas‐De La Garza, Jesus A.; Wallace, Jr, Richard J.
- Abstract
Abstract: Background: Actinomycetoma caused by Nocardia usually responds well to antibiotics. Emerging species of Nocardia, such as <italic>N. wallacei</italic>, can be a therapeutic challenge. Aims: Confirm the therapeutic effectivity of linezolid in multidrug resistant <italic>Nocardia Wallacei</italic> actinomycetoma. Materials and Methods: We evaluated the medical management of an 18‐year‐old man with multidrug resistant actinomycetoma of the left leg caused by <italic>N. transvalensis</italic> complex treated 17 years ago with linezolid 1200 mg a day. This bacteria was recently reclassified as <italic>Nocardia Wallacei</italic> by specific molecular biology technique. Results: The infection was cured after 3 months of treatment; the patient remained asymptomatic for the past 17 years. No adverse effects were found. Discussion: Frequently, strains of <italic>N. transvalensis</italic> complex have aminoglycoside resistance; in this case, we highlight the effectiveness of linezolid for the successful medical management of multidrug resistant actinomycetoma. Conclusion: Linezolid can be an alternative for the treatment of multidrug resistant <italic>Nocardia Wallacei</italic>.
- Subjects
NOCARDIA; LEG diseases; MEDICAL care; PUBLIC health; ACTINOMYCETACEAE
- Publication
International Journal of Dermatology, 2018, Vol 57, Issue 5, p580
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/ijd.13909